Skip to content

Evaluating the Effectiveness of Incentive Spirometry

Evaluating the Effectiveness of Incentive Spirometry

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02952027
Enrollment
160
Registered
2016-11-02
Start date
2016-08-31
Completion date
2018-01-31
Last updated
2018-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atelectasis, Dyspnea, FEV1, FVC, Hospital Length of Stay, Incentive Spirometry, Nursing Workload, Oxygen Requirements, Oxygen Saturation, Pneumonia, Re-intubation, Respiratory Rate

Brief summary

Post-operative pulmonary complications (PPCs) have a major impact on patients and healthcare expenses. The goal of perioperative respiratory therapy is to improve airway clearance, increase lung volume, and mitigate atelectasis. Incentive spirometers (IS) are ubiquitously used to prevent atelectasis and PPCs-implementation of which requires substantial provider time and healthcare expenses. However, meta-analyses have demonstrated that the effectiveness of ISs is unclear due to poor patient compliance in past studies. The goal of this investigation is evaluate the effectiveness of IS on post-operative clinical outcomes. The aims of this investigation are to evaluate 1) if IS use compliance can be improved by adding a use-recording patient reminder alarm, and 2) the clinical outcomes of the more compliant IS users vs. the less-compliant IS users.

Interventions

BEHAVIORALUse-recording, patient-reminder alarm for incentive spirometry

Sponsors

Lifespan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Undergoes any cardiothoracic surgery * Is transferred to the cardiothoracic surgery intermediate (step-down) unit at Rhode Island Hospital * Already prescribed an incentive spirometer as standard-of-care * Followed by any healthcare provider * Ability to sign informed consent and comply with all study procedures including follow-up for up to 1 year

Exclusion criteria

* \<18 years of age * Vulnerable population who in the judgment of the investigator is unable to give Informed Consent for reasons of incapacity, immaturity, adverse personal circumstances or lack of autonomy.

Design outcomes

Primary

MeasureTime frameDescription
Compliance - Does the alarm improve IS use compliance?up to 1 week postoperativelyThe primary outcome will be to compare subjects' absolute IS usage count and hourly percent compliance in the Bell On arm vs the Bell Off arms.

Secondary

MeasureTime frameDescription
Outcomes - Does IS use compliance improve clinical outcomes?up to 1 week postoperatively* Subjective American Thoracic Society's Dyspnea Index43 - administered daily in ICTU * ICTU Day 1: Baseline Dyspnea Index * ICTU Day 2 through discharge: Transition Dyspnea Index * Objective Trend during ICTU stay * Vital signs (T, HR, RR, BP) * O2 saturation * Oxygen requirements * CBC Bedside Pulmonary Function Tests (Micro 1, Carefusion) * Daily FEV1, FVC, FEV6, PEF, FEV1/FVC, FEV1/FEV6 and F25-75 ratios. Wilcox atelectasis severity score44, 45 * Scored 0-5 by daily chest x-ray * Collaboration with Dr. Terrance Healy, Chief of Chest Radiology, RIH Pneumonia * Rate of physician-diagnosed pneumonia * Pneumonia severity index48 Length of ICTU stay Mortality * In-hospital * 30 day post-discharge 30-day readmission rates

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026